To determine the tolerable upper intake level of pyridoxineῌHCl in humans, we investigated the e#ects of excess pyridoxineῌHCl administration on body weight gain, food intake, tissue weight, and urinary excretion of water-soluble vitamins in weaning rats. The weaning rats were freely fed ordinary diet containing 0.0007 pyridoxineῌHCl (control diet) or the same diet with 0.1, 0.5, 0.8 or 1.0 pyridoxineῌHCl for 30 days. The body weight gain in the 0.8 and 1.0 groups, and the total food intake in the 1.0 group were significantly lower than those in the control group. The urinary excretion of pantothenic acid in the pyridoxineῌHCl added groups were higher than that in the control group, while excessive pyridoxineῌHCl intake did not a#ect the urinary excretion of other water-soluble vitamins. These results showed that the no-observedadverse-e#ect-level (NOAEL) for pyridoxineῌHCl was 0.1 in diet, corresponding to 90 mg/kg body weight/day, and lowest-observed-adverse-e#ect-level (LOAEL) was 0.5 in diet, corresponding to 450 mg/kg body weight/day. 
ῶ̱̲ Q Q̳QῢQQQQQῖῌ QQQQ̯Q̳ ̯Q̲ῡQQ̯̮̯ (Fig. 2H ). Each value is expressed as g/100 g body weight and represents the meanῐSEM (nῑ4). ῎pῒ0.05 versus control determined by ANOVA followed by Tukey῍Kramer multiple comparison test. Each value is expressed as the meanῑSEM (nῒ4). ῍pΐ0.05 versus control determined by ANOVA followed by TukeyῌKramer multiple comparison test. 
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